"Clinically predictive preclinical efficacy testing services at your disposal"


Jussi Halleen - CEO, Pharmatest Services

Pharmatest hires new personnel after continuous growth of business

After several years of profitable growth Pharmatest will increase its staff amount by hiring four new employees in early 2016. The turnover of Pharmatest increased by 30% in 2015 compared with 2014, and the growth rate is expected to increase further during 2016 and beyond.

Of the four new employees mentioned above, three have already been identified. These include one new person to support sales and marketing activities, and two laboratory persons. Pharmatest is now accepting applications for the fourth position, a senior scientist. For more details see Senior scientist position.

After several successful years of business Pharmatest received certification of the highest Dun & Bradstreet Credit Worthiness classification a year ago. Dun & Bradstreet rating was based on the business figures of 2014, when Pharmatest was amongst the approximately 4% of all companies in Finland that received the highest classification.

Jussi Halleen, CEO of Pharmatest comments: “After a difficult 1-2 years period that started in September 2008 due to the global finance crisis Pharmatest has now had several consecutive years of profitable growth, and 2015 was the most successful year in the history of Pharmatest. We look very optimistically towards the future, with substantial growth expectations during 2016 and beyond, creating the current need to increase our staff number.”